Non-alcoholic fatty liver disease: The new epidemic and the need for novel nutritional approaches

Journal of Medicinal Food

Volumn 10, Issue 4, 2007, Pages 563-565

  Selmi, Carlo ^a,b,c   Bowlus, Christopher L ^a   Keen, Carl L ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Functional food; Metabolic syndrome; Obesity; Steatosis; Vitamin E

Indexed keywords

DIET THERAPY; EPIDEMIC; FUNCTIONAL FOOD; HUMAN; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL SUPPORT; OBESITY; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

ANIMALS; DIET; DIETARY SUPPLEMENTS; FATTY LIVER; HUMANS; INFLAMMATION; LIFE STYLE; OXIDATIVE STRESS; UNITED STATES; WEIGHT LOSS;

EID: 37549008274     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.620     Document Type: Short Survey

References (29)

1. Alter MJ: Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003;39(Suppl 1):S64-S69.
2. Kim WR: The burden of hepatitis C in the United States. Hepatology 2002;36(Suppl):S30-S34.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
4. Clark JM, Brancati FL, Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-967.
5. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(Suppl):S99-S112.
6. Hahn BH, Grossman J, Chen W, McMahon M: The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007;28:69-75.
7. Gilliam LK, Jensen RA, Yang P, Weigle DS, Greenbaum CJ, Pihoker C: Evaluation of leptin levels in subjects at risk for type 1 diabetes. J Autoimmun 2006;26:133-137.
8. Honda M, Kawai H, Shirota Y, Yamashita T, Takamura T, Kaneko S: cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation. J Autoimmun 2005;25:133-140.
9. Day CP, James OF: Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-845.
10. Endo M, Masaki T, Seike M, Yoshimatsu H: TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 2007;232:614-621.
11. Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Faga E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G: Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005;42:1175-1183.
12. Manco M, Marcellini M, Giannone G, Nobili V: Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 2007;127:954-960.
13. Selmi C, Mackay IR, Gershwin ME: The immunological milieu of the liver. Semin Liver Dis 2007;27:129-139.
14. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-4413.
15. Abbas AK, Lohr J, Knoechel B: Balancing autoaggressive and protective T cell responses. J Autoimmun 2007;28:59-61.
16. Salunga TL, Cui ZG, Shimoda S, Zheng HC, Nomoto K, Kondo T, Takano Y, Selmi C, Alpini G, Gershwin ME, Tsuneyama K: Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 2007;29:78-86.
17. Rukkumani R, Aruna K, Suresh Varma P, Padmanabhan Menon V: Hepatoprotective role of ferulic acid: a dose-dependent study. J Med Food 2004;7:456-461.
18. Senthilkumar R, Nalini N: The potential beneficial effect of glycine on the carbohydrate moieties of glycoproteins in an experimental model of alcohol-induced hepatotoxicity. J Med Food 2004;7:108-113.
19. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-350.
20. Ramesh B, Saravanan R, Pugalendi KV: Influence of sesame oil on blood glucose, lipid peroxidation, and antioxidant status in streptozotocin diabetic rats. J Med Food 2005;8:377-381.
21. Sandhya VG, Rajamohan T: Beneficial effects of coconut water feeding on lipid metabolism in cholesterol-fed rats. J Med Food 2006;9:400-407.
22. Trinidad TP, Loyola AS, Mallillin AC, Valdez DH, Askali FC, Castillo JC, Resaba RL, Masa DB: The cholesterol-lowering effect of coconut flakes in humans with moderately raised serum cholesterol. J Med Food 2004;7:136-140.
23. Samuels R, Mani UV, Iyer UM, Nayak US: Hypocholesterolemic effect of Spirulina in patients with hyperlipidemic nephrotic syndrome. J Med Food 2002;5:91-96.
24. Fujioka K, Greenway F, Sheard J, Ying Y: The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J Med Food 2006;9:49-54.
25. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L: Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food 2004;7:305-308.
26. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S: Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:2485-2490.
27. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ: Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003;38:413-419.
28. Zheng R, Jie S, Hanchuan D, Moucheng W: Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol 2005;5:811-820.
29. Sakaguchi S, Furusawa S: Preventive effects of a traditional Chinese medicine (Sho-saiko-to) on endotoxin-induced cytotoxicity and tumor necrosis factor-alpha production in J774A.1 cells. Biol Pharm Bull 2004;27:1468-1470.